Please ensure Javascript is enabled for purposes of website accessibility

Imax Corp (IMAX) Q1 2020 Earnings Call Transcript

By Motley Fool Transcribers - May 1, 2020 at 4:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

IMAX earnings call for the period ending March 31, 2020.

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

Imax Corp (IMAX -1.76%)
Q1 2020 Earnings Call
Apr 30, 2020, 8:30 a.m. ET


  • Prepared Remarks
  • Questions and Answers
  • Call Participants

Prepared Remarks:


Good day, and welcome to the IMAX First Quarter 2020 Earnings Conference Call. [Operator Instructions]

At this time, I'd like to turn the conference over to Mr. Brett Harriss. Please go ahead.

Brett Harriss -- Senior Vice President of Investor Relations

Thank you, Emma. Good morning, everybody and thank you for joining us on today's first quarter earnings conference call. On the call today to review the financial results are Rich Gelfond, Chief Executive Officer; and Patrick McClymont, Chief Financial Officer. Megan Colligan, President, IMAX Entertainment; and Rob Lister, Chief Legal Officer, are also joining us today.

Today's conference call is being webcast in its entirety on our website. A replay of the webcast will be made available shortly after the call. In addition, the full text of our first quarter earnings press release and the slide presentation have been posted on the Investor Relations section of our website. At the conclusion of this call, our historical excel model will be posted on the website as well.

I'd like to remind you of the following information regarding forward-looking statements. Our comments and answers to your questions on this call as well as the accompanying slide deck may include statements that are forward-looking and that they pertain to future results or outcomes. Actual future results or occurrences may differ materially from the forward-looking statements. Please refer to our SEC filings for a more detailed discussion of some of the factors that could affect our future results and outcomes.

During today's call, references may be made to certain non-GAAP financial measures as defined by Regulation G of the Securities and Exchange Commission. Discussion of management's use of these measures and the definition of these measures as well as a reconciliation to non-GAAP financial measures, including adjusted net income, adjusted EPS and adjusted EBITDA as defined by our credit facility are contained in this morning's press release.

With that, let me now turn the call over to Mr. Rich Gelfond. Rich?

Richard L. Gelfond -- Chief Executive Officer

Thanks, Brett. These are extraordinary times as our world, the entertainment industry and IMAX Corporation confront an unprecedented challenge of COVID-19. As much as we look forward to theaters reopening, we fully support local officials and our exhibition partners around the world in closing theaters as necessary. We'll also be extremely cautious in markets like China, that are beginning to reopen schools, restaurants and other public spaces. I hope all of you joining us are staying healthy and safe.

Today, I'd like to discuss the continued financial strength of IMAX, the health of our brand and our ongoing efforts to enhance The IMAX Experience for our audiences, the condition of our China business, IMAX's contributors in contrasting a formidable upcoming film slate, and finally, our relationship and efforts to support our exhibition partners.

Looking at the first quarter of 2020, clearly, our results were impacted by COVID-19. We reported revenues of $35 million and adjusted EBITDA loss of $4.4 million and adjusted net income loss to common shareholders of $29 million or $0.48 per share. This includes a $0.10 credit provision that Patrick will discuss in greater detail.

We installed 12 IMAX systems in the first quarter and our commercial theater network now stands at 1,526 theaters, up 7.5% versus Q1 of last year. I want to underscore that IMAX is in a strong financial position to weather this crisis.

We entered the year with more than $90 million in net cash on our balance sheet. At the end of March, we drew the balance of our $300 million revolving credit facility to maintain maximum flexibility throughout the duration of theater closures. As a result of this strong cash position and a commitment to controlling costs, we're confident in our ability to operate through an extended shutdown in a zero-revenue environment. We've already taken significant costs out of our 2020 operating structure and we'll continue to be flexible and accordingly -- and respond accordingly as the situation evolves.

With technology and licensing business, we don't have a lot of fixed assets, and we run the business with fewer than 700 full-time employees. Impressive, when you think about how we have grown and managed the global brand, that operates across 81 countries and territories, and our box office was in excess of $1 billion last year. We managed the business conservatively over the preceding years. And as a result, we believe that we have the balance sheet to be ready for exhibitors, studios, filmmakers and audiences when the entertainment industry is back up and running.

Furthermore, as global economies restart, we believe consumers will turn to strong trusted brands like IMAX. Prior to the challenges of 2020, IMAX was coming off two consecutive years of record-breaking global box office. Last year, we set records for global, local language and international box office, including box office records in 27 countries worldwide. We entered 2020 with a record number of releases filmed using IMAX cameras. We have established a unique and powerful position in the entertainment ecosystem. Consumers seek out The IMAX Experience for immersive blockbuster entertainment.

Studios value IMAX as the mark of a must see film and a powerful partner in marketing, curating and driving box office for their biggest releases. The world's best filmmakers and creators are increasingly using our end-to-end technology to bring their artistic vision to life. Exhibitors rely on our theaters to provide a premier experience that drives ticket pricing, volume and differentiation. And finally, streaming services offer new opportunities for us to bring new event content to our theaters and to bring IMAX technology to home entertainment.

This privileged position enables IMAX to take an active role in shaping how the entertainment industry emerges from this crisis. We're also using this time to reshape how we deliver for our audiences. The last time the theatrical business saw a crisis of this magnitude was in the early 2000s, when many of the major exhibitors restructured. And while IMAX is in a far stronger position today, during the last crisis, we fostered many of the innovations that enabled our global growth over the last two decades.

We invented the proprietary digital image [Phonetic] remastering process, which has made IMAX a coveted partner among studios and filmmakers throughout the world. We transitioned our theater operations and technology from analog to digital, and we developed a business model that has driven our theater sales business. We're taking a similar approach in this challenging time. We're accelerating the development of a comprehensive direct-to-consumer strategy to build on the strength of our brand, create new touch points with our audiences and drive more revenue opportunities. We're developing new technologies to bring additional interactivity for our theaters. We're leveraging technologies like artificial intelligence and the cloud to better manage our internal workflows, and we're -- and are enhancing systems to better organize and codify our box office theater and financial data.

Moving to China, our unique position in this market also offers us an insight into the COVID-19 situation. Given our vast network in China where we have more than 700 theaters, IMAX has been managing through the impact of this virus since January. This provides us with an up close, on-the-ground look at the potential trajectory of theater closures and reopenings and consumer behavior patterns, especially as China works to restart its economy.

Schools are opening across China, in-store retail consumption is picking up and TV and film production have also resumed under strict health guidelines, all positive signs. As a matter of fact, just yesterday, a member of the Chinese government announced that he expected theaters to begin opening in early June. When theaters do reopen in China, we believe IMAX will benefit from an exceptional slate. We are prepared to immediately distribute many of the classic titles and are under consideration for release when the theaters resume operations, followed by many of the Hollywood titles earlier in the year that have yet to be seen in China. And of course, the Chinese titles that were originally slated for release over the Chinese New Year.

Additionally, there were positive signs that Chinese audiences are excited to return to their peers. A survey released this month by Chinese ticketing platform, Maoyan, found that 72% of Chinese movie goers are eager to get back to the movies, up from 54% just a month ago.

Turning to the broader film slate. In the back half of 2020 and into 2021, we will participate in a formidable content pipeline with which to relaunch the theatrical business in earnest. Given the uncertainty around theater reopenings, the slate is subject to change, but we've engaged in frequent conversations with our studio partners, for being extremely thoughtful and aggressive to find compelling release windows and serve global audiences in the best way possible.

While we will need to be creative in scheduling, it is clear that studios are deeply committed to theatrical releases for the biggest event movies of the year. There is simply no way to recoup the substantial financial commitment of a blockbuster film without a theatrical release.

In 2020, we are poised to set a new record for releases that are filmed in IMAX with many of the year's biggest films, including, Detective Chinatown 3 in China; Christopher Nolan's latest Sci-Fi film, Tenet; Wonder Woman 1984; the latest James Bond installment, No Time To Die; and Paramount's Top Gun: Maverick.

Schedule for 2021 is an exceptionally strong slate and as of now includes three Marvel titles, included the latest installment of Spider-Man; the highly anticipated new Batman film; new entries from global blockbuster franchises, including Fast & Furious, Mission: Impossible and Jurrasic World; and of course, James Cameron's, Avatar 2, the sequel to the highest grossing IMAX film of all time, currently remain on schedule for next -- the end of next year.

In terms of slate changes, we're mostly seeing release shifts. Studios with big blockbuster products or major film slots, and with a two to three-month delay, many studios are simply shifting their entire schedules as a group. Disney is a great example, where they move Black Widow, originally scheduled for this May, into the November Marvel slot previously held by The Eternals. As a result, 2022 is also currently filled with films such as Thor, Black Panther, Fast & Furious 10 and Mission: Impossible 8, and will hold strong audience appeal for IMAX -- of consumers. The long-term product pipeline is about -- it's robust as it's been. We look forward to working with our studio and exhibition partners to bring audiences the experiences they crave.

In the near term, we have incorporated a number of remote tools into our workflows and a range for select staff to have safe access to our post-production facilities, so we can continue work on forthcoming titles like Tenet. And just as in China, there are early encouraging indications that US audiences are eager to get back to the movie. A survey released by research firm EDO earlier this month revealed that the overwhelming majority look forward to returning to the cinema when theaters reopen, albeit cautiously. More than 70% of respondents said they were likely to return the theaters when they reopen, including 75% of respondents between the ages of 13 and 39, which is the IMAX core audience.

And while shelter-in-place guidelines have clearly driven at-home entertainment consumption, it's also clear that theatrical remains an essential part of the creative vision, consumer proposition, an economic model for blockbuster film making. As I said, the road for blockbuster film making runs through IMAX, and we believe that we're well positioned to reap the benefits of this rich content pipeline as it begins to flow later this year and beyond.

Despite recent challenges, we're hopeful that our exhibition partners will also reap the benefits of a strong slate, and be able to manage through this temporary closure of theaters in the near term. Earlier this month, several exhibitors made important moves to extend their liquidity, lower the risk of bankruptcy and managed through the crisis. The exhibitors are long-standing value partners to IMAX, and these moves drive increased stability that will benefit the whole exhibition industry, entertainment industry and IMAX. We've supported exhibitors as they were forced to close theaters, and we'll continue to support them throughout this situation and beyond.

Agility is a hallmark of IMAX, and our ability to service our partnership with exhibition. As a result, we're confident we can resume installs when conditions improve. We've grown very fast and have the ability to ramp up screen installations quickly. You may recall that in the fourth quarter of 2019, we installed a record 95 systems, which represented more than 50% of our full year installs, and we completed 57 installations in December alone. Additionally, we completed 12 installs in the first quarter of this year, despite the challenges provided by COVID-19 in key strategic markets, including China, Japan, South Korea, India and North America.

Now I'd like to talk about reopening. The process of reopening theaters will be measured and will acquire time for the industry to build the type of theater-going momentum capable of supporting a blockbuster release. But first, we expect theaters to reopen with promotional pricing and library content in cooperation with Hollywood Studios. For the limited reopenings we saw in China, theaters plan to play library content at discounted prices with studios taking a smaller share of the ticket revenue.

We also expect social distancing expectations and regulations to create limited seating arrangement. Given theaters typically operate with substantial excess capacity, we expect the industry in general and IMAX in particular, be able to generate incremental gross margin even with constrained seeding. We also believe that our core audience, the younger fanboys and fangirls that most value an opening weekend blockbuster in IMAX, be the first to resume experiential activities such as movie going.

Let me caution that timing remains highly uncertain. As I said, based on what we've heard from the government in China, we estimate that, that opens in June. With the rest of the world opening sometime in July and August. This of course, is just an estimate. We are fortunate in that unlike most of out-of-home entertainment businesses, it will cost us virtually nothing to reopen IMAX.

If you think of other out-of-home entertainment businesses like sports or theaters, live theater, there's a lot of talent you have to bring in, you have to open a lot of infrastructure and you have to hire a lot of staff. For IMAX as a technology provider, we don't require additional employees or capital to reopen. We figuratively flip the switch. It's a distinct advantage of our technology and services licensing model. Given limited operating costs associated with our business, the first IMAX ticket sold generates incremental cash flow.

To conclude, COVID-19 poses an extraordinary challenge to the entertainment industry and the experienced economy in general. While this is an unprecedented situation and the future is yet uncertain, we believe IMAX is well positioned to meet the challenge, manage the crisis and continue to thrive when it is behind us. We have the financial strength to endure, support our partners in these times to be ready for audiences when they're ready to return to our theaters.

Our brand and The IMAX Experience have been in strong growing demand around the world. We're carefully monitoring Chinese film industry, which in time will drive revenue, along with insights on how to deal with safety, responsibility and effectively relaunch theaters. And when these theaters reopen, we have a remarkably strong pipeline of blockbuster content, and we are actively working the program through next year and beyond. The unique privileged position we built in the ecosystem gives IMAX firm footing in difficult times, and we look forward to continuing our success, driving new opportunities for growth and creating value in a post-COVID-19 world.

Thanks again for joining us today, and please continue to do everything you can to stay safe and healthy. And with that, I'd like to turn it over to Patrick.

Patrick McClymont -- Chief Financial Officer and Executive Vice President

Thanks, Rich and good morning, everyone. I hope you and your families are staying safe through this challenging time. The size and scope of the global pandemic are unprecedented in both magnitude of impact and speed of onset. Because of our large presence in China, we started dealing with these issues earlier than most companies. Thanks to prudent, disciplined and conservative financial management during the last several years, we remain in a strong position to meet the current set of challenges.

Our balance sheet is sound, providing stability to our business and the organization. We are planning for a resumption of our -- while we are planning for business resumption this summer, we remain confident in our ability to operate through an extended business shutdown in a zero-revenue environment.

We ended the first quarter with $352 million of cash on our balance sheet, which includes cash from our revolving credit facility, which we drew down in its entirety in March. We are in close contact with our banking group, which remains supportive of our business, financial strength and transparency.

While the duration of theater closures remains uncertain, we expect our network to reopen well before we exhaust our current liquidity. Based on our current cost structure, we estimate monthly spend of approximately $10 million for operating expenditures. These costs primarily represent our full-time employees, facility costs and fully reflect cost actions executed throughout the first four months of the year that will continue to phase in through the second quarter.

One of the many challenges of the COVID pandemic is uncertainty, while we cannot control when the theaters ultimately will reopen, we can control our operational costs and capital allocation. In late January, almost two months ahead of the US outbreak, theaters in China closed. In response, we took immediate cost action, curtailing some growth initiatives, non-essential capital expenditures, T&E, consulting projects and non-core marketing.

When the epidemic developed into a global pandemic, we took a deeper dive. In March, we completed a bottoms-up analysis of all our costs looking at everything short of a reduction in full-time headcount. We reduced temporary non-staff employees, overtime, consultants and our marketing budget. In April, we moved the majority of our Company to a four-day work week. Departments that lack product demand or not able to effectively function remotely, most notably, those involved in equipment manufacturing and the DMR process, moved to either a two or three days per week schedule.

We expect these measures to reduce costs while maintaining our ability to quickly scale up operations as social distancing measures are lifted and our business resumes. Of course, should the shutdown of theaters last longer than we expect, we have the options to take additional cost measures, reducing our cash burn and extending our cash runway.

Much of our capex is driven by the growth in our joint ventures. Capex associated with our new JV and upgrade JV installations remains dependent on our outlook and that of our partners, which in turn is contingent on the face of construction activity and theater reopenings. As such, we do expect to make continued investments to develop our global network through the balance of the year, albeit at a -- at reduced level compared to recent years.

Excluding investments associated with our joint ventures, we anticipate spending less than $10 million in maintenance capex in 2020. In Q1 2020, we repurchased 2.5 million IMAX shares for $36.6 million or an average of $14.72 per share. IMAX China repurchased 480,000 shares for a total of $890,000 or an average of $1.85 per share. Our ownership of IMAX China now stands at 59.7%.

Turning to our financial results. Before I jump into the details, I'd like to point out that our results were driven by the closure of our China business in late January, and the subsequent closure of the majority of our network throughout March. Please note, we renamed our operating segments to better describe their underlying operating activities. Our network business is now called IMAX Technology Network. Our theater business was renamed IMAX Technology Sales and Maintenance. New business was renamed to New Business Initiatives. The other segment is now Film Distribution and Post-Production.

Total revenue in the first quarter was $35 million, down 56% versus last year. In the first quarter, we saw the IMAX Technology Network business delivered a 91% decrease in gross profit based on a 64% decrease in revenue. Lower revenue and gross margins were driven by the 63% decline in gross box office year-over-year, given the closure of the network.

The IMAX Technology Sales and Maintenance segment delivered gross profit that was down 64%, on revenue down 50%. The decline in gross -- in revenue and gross margin was driven by lower sales and sales-type leases, which numbered two in the first quarter of 2020 versus six in Q1 2019.

The maintenance revenue of $7.4 million declined from $13 million in the previous quarter as we did not recognize maintenance revenue on closed theaters since we could not provide the service. The SG&A, excluding stock-based comp was $24.9 million, down sequentially from the $29 million of expense that was recorded in the fourth quarter of 2019 and up $1.2 million year-over-year. The $1.2 million increase was primarily driven by increased staff costs and a foreign exchange loss, partly offset by decreases in marketing, T&E, events and IT spending.

R&D was up by $1 million. However, this was offset by a corresponding $1 million reduction in projects related to sustained engineering, which hits system cost of sales. In Q2, we expect operating expenses to decrease sequentially through the quarter as we realized the previously discussed cost actions. Adjusted EBITDA for the quarter was a loss of $4.4 million, down from $28.5 million. Net income for the quarter was a loss of $49.4 million or a loss of $0.82 per share, while adjusted net income was a loss of $28.7 million or $0.48 per share versus a positive $0.18 per share last year.

There are two specific items I would like to call out. First, we took a $0.10 per share charge for potential credit losses, principally associated with our theater receivables. This charge represents a conservative reserve given the challenges facing our theater partners. This charge is excluded from our adjusted EBITDA but included in our adjusted net income.

Second, we took a onetime non-cash deferred income tax charge of $0.23 per share related to withholding taxes on historical earnings from our IMAX China business. We had previously planned to indefinitely reinvest these funds offshore. And as a result, did not accrue any withholding taxes that would become due, assuming we repatriated the earnings out of China.

The change in the Company's plans reflects its desire for increased capital allocation flexibility to repatriate cash from China to support dividend payments by IMAX China, including the IMAX Corp. Because of this, we made an approximately 10% tax accrual on $200 million of retained earnings, which relates to the export tax payable upon moving the cash from China to Hong Kong. We expect IMAX China to continue to use its future earnings and cash flow to invest in growing its business. This onetime non-cash charge is excluded from both our adjusted EBITDA and adjusted EPS.

Now, an update on installations. We installed a total of 12 IMAX systems in the first quarter versus guidance of 10. The breakdown for new systems was two sales type leases, one hybrid and two JVs. We also upgraded seven JV locations to IMAX with laser in markets such as Japan and the United States.

To close, while the situation remains uncertain, we are confident IMAX has the financial stability to endure the challenges ahead and be ready to quickly delight our patrons once again when they return to the cinema.

With that, I'll turn the call over to the operator for Q&A.

Questions and Answers:


Thank you. [Operator Instructions] We'll go to our first question today from Eric Wold from B. Riley. Please go ahead.

Eric Wold -- B. Riley FBR -- Analyst

Thank you. Good morning, guys. Just a couple of questions, but just one on the backlog and installation plans, I know it's kind of a little bit cloudy in terms of when that you will start reinstalling IMAX and start kind of opening once again. Can you give a little color on the back...

Richard L. Gelfond -- Chief Executive Officer

Eric, could you talk a little closer to the phone and louder? Hard to hear you, sorry.

Eric Wold -- B. Riley FBR -- Analyst

Sorry, I'll take it off the speaker probably. I know there's still uncertainty in terms of when your -- the theater installs will resume this year, especially in China, but maybe give a little more color on the backlog in terms of how many theaters had been scheduled to install this year prior to the shutdown, maybe security of that backlog in terms of any ability of theaters either cancel or push out? And then if there is kind of a restart or kind of a accelerated restart of the issue in China, what is the ability to kind of really accelerate into year-end and how the holidays and Chinese New Year can make up for lost time, so to speak?

Richard L. Gelfond -- Chief Executive Officer

So in terms of the backlog, Eric, everything in the backlog is legally binding. So there's no unilateral ability of anyone to get out of the backlog. In terms of -- we hadn't yet given installed giants for this year when the pandemic started because when we're supposed to give it, it already happened in China on our year-end call. So we didn't give -- we didn't -- we decided not to give guidance. Even though, it's legally binding, I think there is a possibility that we unilaterally agree with our partners to allow more time for them to install because obviously, if our partner is busy reopening theaters and rehiring, doing things like that, the nature of our relationship isn't one, where we're going to say there's an install date of November 15, you have to do that or we're going to sue you.

So I think the way to think -- I think there'll be a number of installs this year. As you know, there was a fair number in the first quarter. As you saw, there were even signings in the first quarter. But we're not in a position to give guidance now. And I think you should expect that it will be less than usual because of the closure time. I also -- I think it's just a fact that it's going to take some time to reopen. And I don't think people are going to want to manage reopening it to networks at same time as they want to manage a rapid bill. So I hope that's somewhat helpful, Eric

Eric Wold -- B. Riley FBR -- Analyst

Sure. That does help, Rich. Thank you. I guess, the last question is, you talked about obviously the Chinese market probably opens up with library titles, kind of delayed Hollywood and the Chinese New Year titles. As you get past that and get into the back half of the year, which looks to be the week in the US, a fairly healthy and crowded kind of blockbuster film slate. How do you think the Chinese government will handle that over there, given the need still to kind of approve a lot of titles for the back half of the year, how do you think they'll slot them to not let them overlap? And what are your thoughts on how that will be handled over in China?

Richard L. Gelfond -- Chief Executive Officer

So China is always a country where things are weighed against each other. And you're alluding to the fact that they have a stated objective of playing as much Chinese content as they can. But in this instance, I think the balance is going to swing toward getting the economy going again. And I think as we saw late last year, they tended to be more aggressive in letting Hollywood films in and more generous in giving different dates. And given that in China, of the 70,000 screens, a lot of them are in high-profile malls. My bet would be that they're going to allow in a lot of those films in order to encourage the consumer to go back into those malls and spend. And also, I think because production has been closed in China as it has been in the rest of the world, but longer in China after they run through the New Year's movies and some other movies, I don't think there's going to be a lot of original content. But I think both factors will lean toward more Hollywood content.

Eric Wold -- B. Riley FBR -- Analyst

Perfect. Thank you, Rich.


Thank you. We'll go to our next question now from Eric Handler from MKM Partners. Please go ahead.

Eric Handler -- MKM Partners LLC -- Analyst

Yes. Good morning and thanks for the question. Rich, I'm just curious, when theaters start reopening and IMAX screens are part of that, obviously, are you going to be giving any best practices to your exhibitor partners on how they should be managing the screens in terms of sales or how to disinfect this -- the equipment and everything? Is there something that you're saying you'll be telling the partners when that -- when those reopenings happen? Or is everybody going to be operating on their own and every -- but there's no one size fits all for these reopenings?

Richard L. Gelfond -- Chief Executive Officer

Yeah. So, we're in a lot of contact with our exhibition partners, as well as our studio partners on a worldwide basis, I would say, pretty much daily. Someone is talking to someone all of these places. So, it's ultimately the exhibitors' decision on when to reopen, subject to government regulation and how to reopen. But there is very much, Eric, an ongoing dialogue going on. So, we have an internal team that we've put together to assess what's the safest way that we can open our theaters. And I'm sure we wouldn't open them if we don't consider it to be safe. But the exhibitors are taking slightly different approaches or at least in discussion phases. So, one exhibitor is talking about every other seat at the beginning or every other row. Another exhibitor is talking about a new software program, which allows families to stay together in every other seat. There is some international -- Hong Kong, I think, is allowing the theaters to open next week. I think they're talking about a different kind of protocol. So, we have input into those protocols, and we're highly focused on it internally. But -- so I don't think it's they or us deciding. I think there'll be a lot of consultation, and there won't be one size fits all.

Eric Handler -- MKM Partners LLC -- Analyst

So will you be providing maybe some best practices to the western theaters based on what's going on in Asia as they reopen?

Richard L. Gelfond -- Chief Executive Officer

As I said, Eric, it's not like we're mandating these or we're giving people a list. But I think we're in the middle of a broad communication going on. We're kind of -- if you think of a wheel, we're kind of in the center because of a lot of the relationships we have. So we're communicating that on a very regular basis. And I would expect if we say, hey, this is working in Thailand, and this isn't working in Korea, you guys should look at this. I mean, we're partners. I think we're going to figure it out together, although ultimately, it's their responsibility.

Eric Handler -- MKM Partners LLC -- Analyst

Thank you very much.


Thank you. Our next question now comes from Chad Beynon from Macquarie. Please go ahead.

Chad Beynon -- Macquarie Research -- Analyst

Hi. Good morning, Rich, Patrick. Hope you're well. Wanted to, I guess, continue the discussion on that last question, maybe asking it a different way. Can you, I guess, help us think about maybe seat occupancies or screen occupancies on the weekends or during big releases? We're just trying to figure out how to think about indexing in the social distant, I guess, near-term opening world. And kind of how this could look? Obviously, you've put up some pretty incredible indexing. And if Tenet is the first movie, I don't think we should assume it should be as strong as the Dunkirk, or some of your historically successful film. So, could you just kind of help us think about where occupancies are? And if you can adjust screen times and some of those things? Thanks.

Richard L. Gelfond -- Chief Executive Officer

Sure. Well, first of all, no one at IMAX has seen it yet, but I've heard the movie is incredible and furthers the crystal and legend of doing really cutting-edge phenomenal storytelling. So I really look forward to that. And I know Chris really would like to be, come out with the film that open for theaters, but that's up to a lot of things, including government regulations and the virus and all sorts of things. So, we've started to study the capacity issues. And as you probably know, a successful cinema chain over a long period of time, the occupancy rates are in the 15% to 20% range. It's -- so one way to think about it is that they have a big multiplex and they have a lot of screens in it, depending how much product they have, they can do pretty well with capacity constraints.

IMAX, since it's a single-screen theater has a different issue because let's say arbitrarily at the beginning capacity is going to be set at 50%. And by the way, I should stop there and say, there are no real rules on that, where that comes from is what was talked about in China, but no one has said that, that's what's going to happen. But I think if that happens, that will be for a period of time. And then after that period of time elapses, there'll be adjustments made to that. But if you look at the IMAX numbers, and we've done some work on it, if a film opens in the US to around $150 million a year, like if you look back at Captain Marvel last year, the IMAX capacity utilization on the opening weekend is around 50%. So that would mean that we wouldn't lose much. We wouldn't lose anything if the movie was $150 million or less. If there are bigger openings like Endgame, even that movie, by the second weekend that was down to about 50% capacity utilization in IMAX. So the place where it really would affect us will be opening weekend for a big movie on select days, Thursday, Friday, Saturday nights. And part of the goal of our marketing would be to figure out how we can move people from Saturday night by way of example, to Tuesday night or Tuesday afternoon. And I think given the brand association between someone like Chris Nolan, and IMAX, I actually think that, that's likely to happen, and we'll design marketing tools around that.

Chad Beynon -- Macquarie Research -- Analyst

That's great. Thanks, Rich. And then, lastly, just regarding the financial situations with your exhibition partners. Are there other things that you're considering to help them get through this period, whether it's sale leasebacks on their equipment, I'm guessing most of them are in JV or hybrids or delaying receivables? And then, also on that, and it's a different time, but when many of the exhibitors went through the bankruptcy process, I guess, that was 20 years ago, did they close or change any of the arrangements with you guys? Or was that just too long ago to really have a data point on that? Thanks.

Richard L. Gelfond -- Chief Executive Officer

Oh, I remember that time very well. And no, they didn't really -- the amount of theaters that were changed or canceled was de minimis. It was next to nothing. I think there were a couple. So no, but we -- our arrangements with the exhibitors, I mean, they're our partners. The really good news for them and for us is that, I think the capital markets in the last several weeks have been quite amenable to financing exhibitors through this crisis. And I'm sure you saw Cinemark raise $250 million, AMC recently raised $500 million. So I think there are pretty good financial footing now where I don't really see a bankruptcy as a significant risk to a number of chains right now. I think there have been some smaller regional operators. But as far as we can tell right now, we don't think that's going to be a significant problem.

With that said, we've been in business with a lot of these people for a long time. And before some of these financings were completed, we said to some of our partners that we're going to work with you. So, if you need to slow down installation, we understand that. If you need to slow down your payables, we understand that. And now that they've returned to financial health, I think we want a more normalized business relationship with those that aren't, I think we're going to work with them. We're not in the business for one quarter over one quarter. We've been in business for over 50 years, and one reason is we know how to work with our partners. And I think we'll continue to have that philosophy.

Chad Beynon -- Macquarie Research -- Analyst

Thank you. Best of luck.


Thank you. We'll now go to our next question now from Mike Hickey from Benchmark Company. Please go ahead.

Michael Hickey -- The Benchmark Company -- Analyst

Hey, Rich, Patrick. Hope you guys are good. Thanks for taking my questions. Just two. First, thinking about maybe more of the economic strain that the world is going to sort of deal with here. The recessionary environment that we're clearly in, can you just remind us sort of how moviegoers behave in a recessionary environment? And how they sort of choose between the premium ticket and maybe a cheaper ticket? And I have a follow-up.

Richard L. Gelfond -- Chief Executive Officer

The movie business, in general, tends to perform quite well in recessions. In fact, I think people see it as an affordable luxury. They might cut out a trip or a restaurant if they're open or vacation or things like that. But movies are still relatively low-priced way to escape and get away. And historically, cinemas have done well in downtimes. In fact, we looked at our own data from the post 9/11 period, and the 2009 financial crisis, and our box office was either flat or up during that period of time. So, I don't really see that as a significant headwind.

Michael Hickey -- The Benchmark Company -- Analyst

Thanks, Rich. That's helpful. The second question, I guess, this is not your first pandemic, obviously, this one is at a scale. I don't think we all -- anyone has ever experienced before, but just sort of curious what you've learned from prior pandemics and moviegoers willingness to bounce back?

Richard L. Gelfond -- Chief Executive Officer

So the only real reference point we have was the SARS situation in Hong Kong and to some extent, in Canada. So, what I remember from Hong Kong was that they opened a little bit slow and were down year-over-year for the first few months, but the back end of the year, when they reopened, they were significantly up from the prior year. Again, I'm not sure it's a brain analogy because, as you say, it was a lot smaller and a lot more isolated, but that's really the only data point we have.

Michael Hickey -- The Benchmark Company -- Analyst

All right. Thanks, guys. Best of luck for the future [Phonetic].


Thank you. We will now go to our next question from Alexia Quadrani from J.P. Morgan.

Alexia Quadrani -- J.P. Morgan -- Analyst

Thank you. Thank you very much. The -- two questions. First is, do you see the studios perhaps reluctant to release films initially post reopening given lower luxury capacity suggesting the slate could be pushed out further?

And then my second question, Rich, is do you see windows changing, I guess, following this current style, Universal and more companies potentially considering hybrid of kind of PLF versus theatrical? And, I guess, along those lines, does the tighter -- does the potentially tighter window really impact your NOI?

Richard L. Gelfond -- Chief Executive Officer

I'll start there and say, no, the window doesn't impact us that much because the typical IMAX movie plays for two weeks or less. If it's a Chris Nolan movie, it's an outlier. But wherever the windows end up, the -- it won't have a great impact on IMAX. I'll get back to the studio one, but on stability -- on the windows question.

But on the studios being reluctant. It's a complicated answer, Alexia, that's because there are a lot of factors. On the one hand, yes, the studio wants to make sure the theaters are back to capacity. They want to make sure as many people see their movies as they can. On the other hand, a lot of these movies have a lot of capital tied up, the big carrying costs and their ancillary windows that flow off of the theatrical window, and they have their own reporting issues and their own accounting issues. And they want to get on that stream rolling. So that's an incentive to go quicker. As I mentioned before, certain filmmakers are very anxious to have their movies release. So, I don't know anyone in America who's pushing harder than Chris Nolan to get the theaters open and to get his movie released in July when it's scheduled for. So it's really a balance. And I think it's -- I've frankly never seen closer cooperation of the studios and the exhibitors than now. There's just almost a daily dialogue going on for everybody's trying to assess when are the likely opening dates, and what is the optimal time. And I think people are really working together to make it happen.

And I'll say before I transition to your next question about windows that I think one of the things that people aren't talking about, they're talking about the Trolls experiment, which you're alluding to. But from my point of view, the bigger headline coming out of the pandemic is that, virtually every blockbuster has been rescheduled for theatrical release day. So pause on that one for a second. So people have been speculating about the windows for a really long period of time. And ever -- if ever there was a time to lose a theatrical release, it would be now. And it just hasn't happened. And I think that reinforces the value of the theatrical window to the studios and to the film makers.

Now, in terms of Trolls and the Universal's situation, I think Universal had a bit of special circumstances because they're moving. They had already started the marketing campaign. They eventually had $50 million in costs in the marketing campaign that was scheduled for April release. So I think they've faced a tough decision if they postponed, if they would have had a relaunch at another time, and respend that money. So I think they decided to go on streaming. It was kind of a unicorn event. Families were sitting at home, kids were sitting at home, by their account, it did pretty well in streaming. And, I guess, that's not surprising, given that there were no competitive movies and not very much else to do, especially for families. I don't think that changes the model. I don't -- I think if you allow movies to release on streaming rather than theatrical, you would lose so many ancillary windows. There wouldn't be an electronic self window. There wouldn't be a streaming window. There wouldn't be a TV window, which queues off a box office. So that model just doesn't makes very much sense to me. And certainly, does't make sense for blockbuster releases. And the evidence is in the fact that they've all been rescheduled.

Alexia Quadrani -- J.P. Morgan -- Analyst

Thank you.


Thank you. We will now go to our next question today from Aravinda Galappatthige from Canaccord. Please go ahead.

Aravinda Galappatthige -- Canaccord Genuity -- Analyst

Good morning. Thanks for taking my questions. Two for me. First of all, for Rich, on the -- when you consider the financial challenges that are faced by the exhibition partners. Especially when it comes to the joint revenue-sharing agreements, is there a possibility that you might have to make sort of bigger concessions to them? I mean, potentially, if there are sort of footprint changes, how much flexibility would they have in terms of perhaps reducing the count -- the existing count? And what options did you have in such a situation? And with respect to the economy, the economics of the joint revenue-sharing agreements, is there a prospect of potentially having to offer them some sort of flexibility, either on permanent basis or on a temporary basis?

And my second question is around receivables. Patrick, I was wondering if you can provide us with sort of the flow in terms of receivables during the month of April? Obviously, during May, it's about a $65 million balance there. I suspect the vast majority is with the exhibition partners. Can you talk to sort of the duration and sort of the floor you've seen since the end of the quarter? Thanks.

Richard L. Gelfond -- Chief Executive Officer

I'll answer your first question, which is, as I said to you before, the exhibitors are in pretty good shape right now, thanks to the capital markets and the prudent moves that they've made. We carefully negotiate all of our agreements, including our joint venture agreements on a worldwide basis and they're binding contracts. So no, I don't think there'll be changes to those agreements. I think both of us put up a lot of capital in the JVs, and we have model returns, and we expect those returns.

With that said, when you talk about temporary, I mean, there are things like I mentioned earlier, that they want to delay of rolling out some joint ventures to preserve their own capital, and that makes sense for them. So certainly, we would consider delaying it. There were other kinds of things that provided them temporary relief through a tight period of time. We're in business with them for a very long period in time and intend to be, but fundamentally changing our business deal is not something that we would entertain.

Patrick, do you want to answer the other question?

Patrick McClymont -- Chief Financial Officer and Executive Vice President

Sure, happy to. The way we look at the receivables now, I mean, short-term, we focus on our build and our accrued accounts receivable, it's about two-third of that is on the exhibitor side and about one-third is on the studio side. And as you'd expect, we haven't seen really any change on the studio side. We do expect on the exhibitor side, we'll start to see some changes as the exhibition -- the theaters are closed right now. We're in discussions with all of our exhibitor partners and so have clear line of sight on this. And as Rich said, more broadly, these are our partners, and we're going to figure out ways to be helpful. As we talked about on the call, we did take a reserve against certain receivables. A lot of that was related to the launch of CECL, the new accounting provision, which obviously was implemented during a particularly interesting quarter with everything that was going on. So we think we're well protected in that event.

And then in terms of concentration, it's what you'd expect. It's our big partners. And of that build and accrued AR, about 20% of it is across our top three to five partners. So there's not a whole lot of concentration. So we think we're in a reasonably good spot, and we're monitoring it very closely.

Aravinda Galappatthige -- Canaccord Genuity -- Analyst

Thanks very much.


Thank you. We will now go to a question from Vasily Karasyov from Cannonball Research.

Vasily Karasyov -- Cannonball Research -- Analyst

Good morning. Rich, I wanted to follow-up on what you've said about blockbusters being rescheduled and so on. So, if we look three, six, nine months after the movie theaters reopen. So, there will be -- one could say that there would probably be a glut of blockbusters and IMAX kind of titles because you have a backlog that will be released, and then the new productions will be coming up, and there are only so many opening frames in a year. So one way to look at it would be to say, it would be good for IMAX because the share of IMAX movies of the box office would increase because bigger titles would push out smaller sort of Lionsgate kind of films. Or another way would be to see -- to say that that could lead to cannibalization in -- revenue cannibalization for you. So, I was wondering if you could help us think through that dynamic. Am I thinking about that wrong?

Richard L. Gelfond -- Chief Executive Officer

I wouldn't say wrong, Vasily. But I think that most IMAX movies only play for one or two weeks. So I -- and there are a lot of movies that we have to program in the interim, that are kind of fillers. So I think if that problem you're describing came to be, if there was adequate spacing in the movies. And hopefully, we'd work with the studios to ensure that there was, it would be a good period of time for us.

I would add, though, that part of this pandemic has shut down production for a few months, and we don't know how and when it's going to open. So, even though it looks good right now for 2021, I think these things, like water that rises to its level, I think that the -- this extreme glut you're expecting rather than coming all at the beginning of the year, will probably spread itself up as production comes back online. So I don't think that's really going to be a significant issue.

Vasily Karasyov -- Cannonball Research -- Analyst

All right. Thank you.


Thank you. As we have no further questions, I would now like to turn the conference back over to Rich Gelfond for any additional or closing remarks.

Richard L. Gelfond -- Chief Executive Officer

Thank you all so much for joining us. Needless to say, it's been a very trying period for us at IMAX. And obviously, we're a tiny part of the world and especially the healthcare workers and sick people on the frontlines. We've been using this period to try and innovate, prepare, move forward and come back with a bang. It's hard to believe that it's only a few months ago that we had a record year and terrific earnings, which we released in February. And by any measure, if those return, I think we're in really -- when the theaters open, if -- when they open on a rolling global basis, I think we'll be in a really good spot to flourish once again. And we're grateful for all of you being with us today, and I want to especially thank our employees through this whole situation, and thanks for joining.


[Operator Closing Remarks]

Duration: 60 minutes

Call participants:

Brett Harriss -- Senior Vice President of Investor Relations

Richard L. Gelfond -- Chief Executive Officer

Patrick McClymont -- Chief Financial Officer and Executive Vice President

Eric Wold -- B. Riley FBR -- Analyst

Eric Handler -- MKM Partners LLC -- Analyst

Chad Beynon -- Macquarie Research -- Analyst

Michael Hickey -- The Benchmark Company -- Analyst

Alexia Quadrani -- J.P. Morgan -- Analyst

Aravinda Galappatthige -- Canaccord Genuity -- Analyst

Vasily Karasyov -- Cannonball Research -- Analyst

More IMAX analysis

All earnings call transcripts

AlphaStreet Logo

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

Motley Fool Transcribers has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

IMAX Corporation Stock Quote
IMAX Corporation
$16.20 (-1.76%) $0.29

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.